5-APB

Research chemical

A triple monoamine reuptake inhibitor. This agonism for 5-HT2B makes it likely that 5-APB would be cardiotoxic with long term use, as seen in other 5-HT2B agonists such as fenfluramine and MDMA.

5apb

Extended library — TripSit data only (PolyForm Noncommercial 1.0.0).

Before you dose

⚠This substance's dose is not reliably weight-scaled - the ranges shown are population figures. Sensitivity varies far more between people than body mass explains.

Dose

Published population range

Light40–60 mg

Common70–100 mg

Strong≥ 100 mg

No weight-based model. Unknown potency — start far below any published figure.

Check an amount you already have

Expected effects

Largely
Effects reported were similar to that of the drug mda
With euphoria
Empathy
Sedative
Sometimes stimulating effects

Harm reduction

This entry comes from the extended library: it is a less-studied substance with fewer independent sources.
Unknown potency is the main risk with novel substances — start with a fraction of any published figure and never re-dose before the full onset has passed.
Test with reagents and, where possible, a lab service. Fentanyl and nitazene contamination is not detectable by eye or by reagent alone.
Avoid using alone, and do not combine with other drugs while you are learning how a new substance affects you.

Tolerance, dependence and detection

Detection windowMay cause false positives for MDA (1-5 days)

Sources

• TripSit wiki (PolyForm Noncommercial)
http://wiki.tripsit.me/wiki/5apb

Dosina is educational harm-reduction information, not medical advice. Doses are population ranges from published sources and cannot account for your tolerance, health conditions or what is actually in your substance. Possession and use may be illegal where you live.